Searched for
LEVETIRACETAM
More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...31 May, 2026, 01.34 PM IST- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...28 May, 2026, 11.04 PM IST
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...24 May, 2026, 04.23 PM IST
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...01 May, 2026, 11.01 PM IST
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...29 Apr, 2026, 11.57 PM IST
- Dr Reddy's, Lupin recall products in US due to labelling, manufacturing errors: USFDADr. Reddy's Laboratories and Lupin are recalling products in the US due to labeling and manufacturing issues. Dr. Reddy's is recalling an a...22 Apr, 2025, 05.46 PM IST
- Dr Reddy’s shares in focus after recall of mislabelled Levetiracetam injection in USThe potential risks include hypersensitivity reactions, liver injury, hematological toxicity, drowsiness, dizziness, respiratory depression...17 Mar, 2025, 08.17 AM IST
- Dr. Reddy’s recalls mislabelled Levetiracetam injection in the US; patients likely to experience 'adverse' eventsDr. Reddy’s Laboratories is recalling a batch of Levetiracetam injection bags in the U.S. due to incorrect labeling, which could result in ...13 Mar, 2025, 05.36 PM IST
- Aurobindo Pharma surges 5% on getting USFDA approval for LevetiracetamAurobindo's Levetiracetam in Sodium Chloride Injection is a generic equivalent of HQ Specialty Pharma Corp's Levetiracetam in Sodium Chlori...09 Jan, 2017, 10.27 AM IST
- Aurobindo gets USFDA nod for epilepsy, arthritis drugsLevetiracetam injection is used for treatment of partial onset seizures, myoclonic seizures in patients with juvenile myoclonic epilepsy, a...02 Feb, 2016, 12.53 PM IST
- SPARC gets USFDA nod for its anti-epileptic drug ELEPSIA XR"Approval of ELEPSIA XRTM as 1,000 mg and 1,500 mg once a day tablets will be very useful for these patients and physicians."04 Mar, 2015, 01.30 PM IST
- Sun Pharma recalls 3,263 bottles of epilepsy drug in USAs per the information available, Sun Pharma Global Fze, a US-based unit of the company, is recalling the drug for failing "dissolution spe...23 Feb, 2015, 07.00 PM IST
- Lupin gets final US FDA nod for generic anti-epileptic drugLupin is the 5th largest generics player in the US (by prescriptions), the only Asian company to achieve that distinction.14 Sep, 2011, 04.11 PM IST
- Orchid receives USFDA nod for anti-epileptic tabletsOrchid Chemicals & Pharmaceuticals said it has received US FDA's approval to sell anti-epileptic levetiracetam tablets in the American mark...09 Aug, 2010, 02.26 PM IST
- Sun Pharma gets US regulator's nod for epilepsy drugDrug maker Sun Pharmaceutical Industries on Thursday said it has received the US health regulator's nod for marketing a generic version of ...17 Jun, 2010, 02.22 PM IST
- Lupin gets FDA nod for Levetiracetam TabletsDomestic drug maker Lupin on Friday announced that its US subsidiary, Lupin Pharmaceuticals, Inc. (LPI) has received the final approval for...16 Jan, 2009, 03.35 PM IST
- Orchid, Glenmark, Lupin & Aurobindo Pharma get US nod for LevetiracetamOrchid Pharmaceuticals, Glenmark Pharmaceuticals, Lupin and Aurobindo Pharmaceuticals have all received US FDA approval for their abbreviat...16 Jan, 2009, 01.34 PM IST
Load More
